Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?

Because of the recent success of monoclonal antibody checkpoint inhibitors, and the disappointing results of most therapeutic cancer vaccine trials, it has been questioned whether there is any potential role for such products going forward. In my opinion the answer is "yes" based on the fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Robert O. Dillman (Author)
Formato: Livro
Publicado em: Taylor & Francis Group, 2017-03-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível